Preventing kidney failure in type 2 diabetes
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at ways to slow down kidney damage in people who have had type 2 diabetes for several years. It aims to keep your kidneys working longer and prevent further decline.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older.
- You have had type 2 diabetes for more than 5 years.
- Your kidney function (eGFR) is between 45 and 90, showing early kidney damage.
- You have a small amount of protein in your urine (microalbuminuria).
- You have a regular general practitioner you see for your diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how diet affects the progression of chronic kidney disease in people with type 2 diabetes. If you join, you may receive dietary guidance to help slow kidney decline.
This study tests whether a new care plan for people with diabetes and kidney disease can reduce the risk of serious heart and kidney events. It aims to improve outcomes by closely following patients in routine care.
This study is looking at different kidney health patterns in people with diabetes, especially diabetic kidney disease and people who have not developed kidney damage despite long-term diabetes. It may help researchers understand why kidney problems happen—and what protective factors might prevent them.
This study tests a traditional Chinese medicine treatment approach to delay the progression of diabetic kidney disease to end-stage kidney failure. It may help people with type 2 diabetes who already have kidney damage and are looking to protect their kidneys.
This study tests a program to help primary care doctors better screen and manage kidney problems in people with type 2 diabetes. It aims to see if using recommended medicines can slow kidney disease and improve health.
This Phase 2 study compares tofogliflozin to metformin to see how well they reduce urine albumin levels (a marker of kidney stress) in people with diabetic kidney disease. You might benefit if your type 2 diabetes is affecting your kidneys despite standard blood-pressure medicines.
Hear when a new Renal Insufficiency and Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.